HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of Euro-Global Conference on Biotechnology and Bioengineering

September 28-30 | Hybrid Event

September 28-30, 2026 | London, UK

Red Biotechnology

Red Biotechnology

Red biotechnology, also known as medical biotechnology, refers to the branch of biotechnology that focuses on the application of genetic engineering and molecular biology to develop innovative medical products and treatments. Unlike green biotechnology, which revolves around agriculture, or white biotechnology, which centers on industrial applications, red biotechnology is dedicated to advancements in healthcare. This field encompasses the development of pharmaceuticals, diagnostic tests, gene therapies, and vaccines. Researchers in red biotechnology work on understanding and manipulating biological processes at the molecular level to create novel medical solutions. Examples of red biotechnology applications include the production of genetically engineered drugs, stem cell therapies, and personalized medicine tailored to an individual's genetic makeup. The continuous progress in red biotechnology holds promise for groundbreaking advancements in medical science and the improvement of healthcare outcomes.

Committee Members
Speaker at Biotechnology and Bioengineering 2026 - Murray Moo Young

Murray Moo Young

University of Waterloo, Canada
Speaker at Biotechnology and Bioengineering 2026 - Limongi Tania

Limongi Tania

University of Turin, Italy
Speaker at Biotechnology and Bioengineering 2026 - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

Universidad Autonoma de Baja California, Mexico

Submit your abstract Today

Watsapp